Advanced Biomed Inc. Common Stock

ADVBNASDAQ • USD
ThemeHealthcare - Oncology›Cancer Diagnostics & Biomarkers
4.17 USD
↘ 0.09 (2.11%)AT CLOSE (11:59 AM EDT)
4.18
↗ 0.01 (0.12%)
POST MARKET (AS OF 07:28 PM EDT)
Post Market
AS OF 07:28 PM EDT
4.18
↗ 0.01 (0.12%)
🔴Market: CLOSED
Open?$4.27
High?$4.39
Low?$4.14
Prev. Close?$4.26
Volume?6.6K
Avg. Volume?223.8K
VWAP?$4.28
Rel. Volume?0.03x
Bid / Ask
Bid?$3.53 × 100
Ask?$5.12 × 100
Spread?$1.59
Midpoint?$4.33
Valuation & Ratios
Market Cap?6.9M
Shares Out?1.7M
Float?6.6M
Float %?30.6%
P/E Ratio?1.30
P/B Ratio?0.75
EPS?$3.20
Dividend?0.00%
Ex-Dividend?N/A

ADVB is currently priced at $4.17. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (57.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ADVB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Themes
Healthcare - Oncology›Cancer Diagnostics & BiomarkersHealthcare - Genomics & Precision Medicine›Precision Medicine PlatformsMedical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
31
Market Cap
6.9M
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.advanbiomed.com
Listed
2025-03-06
Address
401 RYLAND ST
RENO, NV 89502
Phone: 86-21-20510823
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
98
Momentum?
77
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?4.91Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.06%Low
Short Interest?3.7K
Days to Cover?1.0
Free Float6.6M
Avg Daily Volume522.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.38Strong
Quick Ratio?7.38Strong
Cash Ratio?1.83Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
1.3CHEAP▾
P/B?
Peers
100
S&P
97
0.75CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
92
57.3%STRONG▾
ROA?
Peers
50
S&P
97
49.6%STRONG▾
Cash Flow & Enterprise
FCF?$-2943727
Enterprise Value?$4.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist